TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00258557
Recruitment Status : Completed
First Posted : November 24, 2005
Last Update Posted : June 26, 2013
Information provided by (Responsible Party):
Tibotec Pharmaceuticals, Ireland